Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000041987 | SCV004039276 | pathogenic | Tuberous sclerosis syndrome | 2023-08-01 | criteria provided, single submitter | clinical testing | Variant summary: TSC1 c.1101_1114del14 (p.Asp368LeufsX3) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251304 control chromosomes (gnomAD). c.1101_1114del14 has been reported in the literature in individuals affected with Tuberous Sclerosis Complex (e.g., Au_2007, LOVD database). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication was ascertained in the context of this evaluation (PMID: 17304050). No submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. |
Tuberous sclerosis database |
RCV000041987 | SCV000065767 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |